Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

U.S. News

NIAID Establishes Consortium to Research, Develop HIV Vaccines

July 18, 2005

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

The NIH National Institute of Allergy and Infectious Diseases on Thursday announced funding to establish the Center for HIV/AIDS Vaccine Immunology, a consortium of universities and medical centers that will work together to develop an HIV vaccine, the Raleigh News & Observer reports. Barton Haynes, a researcher at Duke University Medical Center, will lead the consortium, which will receive $15 million in its first year and might receive a total of more than $300 million over seven years (Avery, Raleigh News & Observer, 7/15). The consortium will focus on understanding the early stages of HIV infection and how human and monkey immune systems respond to the virus, developing and testing HIV vaccines that can stimulate lasting immune response, and evaluating potential HIV vaccine candidates in small clinical trials. The consortium will be a "key component" of the Global HIV Vaccine Enterprise, a virtual consortium of independent organizations dedicated to speeding research on HIV/AIDS vaccines, according to NIAID Director Anthony Fauci (NIAID release, 7/14).

Back to other news for July 18, 2005


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More News and Analysis on Vaccines for HIV Prevention

Tools
 

Advertisement